Biotech company Sarepta Therapeutics (NASDAQ:SRPT) will be reporting results tomorrow after the bell. Here’s what you need to ...

We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to ...

In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...

Entrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...

Following a more than two-year-long hold, Entrada Therapeutics can get its Duchenne muscular dystrophy candidate back on ...

Ukraine war latest: Moscow contradicts Trump over peacekeepers - as UK issues warning to 'menace' Russia Sir Keir Starmer announces an increase in defence spending as he says the UK must back ...

There is a broad reckoning in Ukraine: Washington can no longer be relied upon as a supporter. But Kyiv still has agency on the battlefield and can seek increased support from Europe. By ...

The United States opposed a resolution demanding Russian withdrawal from Ukraine, but won Security Council approval of one calling for peace without assigning blame, exposing fissures between ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...